Alnylam Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Alnylam Pharmaceuticals Inc in one report.
- Save hours of research time and resources with
our up-to-date Alnylam Pharmaceuticals Inc Strategy Report
- Understand Alnylam Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company with focus on the development and sale of innovative medicines based on RNA interference (RNAi). The company’s focus on R&D activities, geographical presence and lead product Onpattro are its major strengths, even as a history of operating losses and legal proceedings could be a cause for concern. The company could benefit from market potential for hemophilia A and B, new product approval, and strong product pipeline. However, its performance could be affected by competitive environment, government regulations and uncertain R&D outcomes.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer